Pulmonary susceptibility of neonates to respiratory syncytial virus infection: a problem of innate immunity?

Archive ouverte

Drajac, Carole | Laubreton, Daphnée | Riffault, Sabine | Descamps, Delphyne

Edité par CCSD ; Hindawi Publishing Corporation -

International audience. Human respiratory syncytial virus (RSV) is a common and highly contagious viral agent responsible for acute lower respiratory infection in infants. This pathology characterized by mucus hypersecretion and a disturbed T cell immune response is one of the major causes of infant hospitalization for severe bronchiolitis. Although different risk factors are associated with acute RSV bronchiolitis, the immunological factors contributing to the susceptibility of RSV infection in infants are not clearly elucidated. Epidemiological studies have established that the age at initial infection plays a central role in the severity of the disease. Thus, neonatal susceptibility is intrinsically linked to the immunological characteristics of the young pulmonary mucosa. Early life is a critical period for the lung development with the first expositions to external environmental stimuli and microbiota colonization. Furthermore, neonates display a lung immune system that profoundly differs to those from adults, with the predominance of type 2 immune cells. In this review, we discuss the latest information about the lung immune environment in the early period of life at a steady state and upon RSV infection and how we can modulate neonatal susceptibility to RSV infection.

Suggestions

Du même auteur

Control of nonatal type I interferon responses by IRAP upon RSV infection

Archive ouverte | Drajac, Carole | CCSD

Control of nonatal type I interferon responses by IRAP upon RSV infection. IRAP 2017, 3rd international symposium

Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis

Archive ouverte | Jacque, Emilie | CCSD

International audience. Respiratory syncytial virus (RSV) is a public health concern that causes acute lower respiratory tract infection. So far, no vaccine candidate under development has reached the market and the...

Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice

Archive ouverte | Remot, Aude | CCSD

Respiratory syncytial virus (RSV) causes severe bronchiolitis in infants worldwide. The immunological factors responsible for RSV susceptibility in infants are poorly understood. Here, we used the BALB/c mouse model of neonatal RS...

Chargement des enrichissements...